American Healthcare REIT (NYSE:AHR – Free Report) had its price target upped by KeyCorp from $43.00 to $55.00 in a report released on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the stock.
AHR has been the topic of a number of other research reports. Weiss Ratings reiterated a “hold (c)” rating on shares of American Healthcare REIT in a research note on Wednesday, October 8th. Robert W. Baird initiated coverage on shares of American Healthcare REIT in a research report on Friday, July 18th. They set an “outperform” rating and a $41.00 price target on the stock. Citizens Jmp increased their price target on shares of American Healthcare REIT from $50.00 to $60.00 and gave the company a “market outperform” rating in a research note on Monday. Truist Financial boosted their price objective on shares of American Healthcare REIT from $44.00 to $46.00 and gave the stock a “buy” rating in a research note on Tuesday, August 26th. Finally, UBS Group assumed coverage on shares of American Healthcare REIT in a report on Friday, September 19th. They issued a “buy” rating and a $51.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $49.40.
Get Our Latest Stock Report on AHR
American Healthcare REIT Stock Up 0.3%
American Healthcare REIT Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th were given a dividend of $0.25 per share. The ex-dividend date was Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a yield of 2.1%. American Healthcare REIT’s dividend payout ratio (DPR) is presently 714.29%.
Insider Transactions at American Healthcare REIT
In related news, Director Jeffrey T. Hanson sold 20,010 shares of the firm’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $49.68, for a total transaction of $994,096.80. Following the transaction, the director directly owned 21,798 shares of the company’s stock, valued at approximately $1,082,924.64. This trade represents a 47.86% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Mark E. Foster sold 3,850 shares of the business’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total transaction of $161,276.50. Following the completion of the sale, the executive vice president directly owned 59,100 shares of the company’s stock, valued at $2,475,699. This represents a 6.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 25,360 shares of company stock valued at $1,229,398 over the last quarter. Company insiders own 0.92% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of AHR. Vanguard Group Inc. increased its stake in shares of American Healthcare REIT by 2.7% during the third quarter. Vanguard Group Inc. now owns 23,529,739 shares of the company’s stock valued at $988,484,000 after purchasing an additional 611,809 shares in the last quarter. State Street Corp grew its stake in shares of American Healthcare REIT by 6.5% in the 2nd quarter. State Street Corp now owns 6,902,944 shares of the company’s stock worth $255,289,000 after buying an additional 422,931 shares during the last quarter. Invesco Ltd. increased its position in American Healthcare REIT by 15.9% during the 2nd quarter. Invesco Ltd. now owns 5,820,530 shares of the company’s stock valued at $213,846,000 after buying an additional 798,075 shares in the last quarter. Alliancebernstein L.P. raised its stake in American Healthcare REIT by 16.7% during the second quarter. Alliancebernstein L.P. now owns 5,318,866 shares of the company’s stock valued at $195,415,000 after buying an additional 759,501 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in American Healthcare REIT by 20.5% during the second quarter. Geode Capital Management LLC now owns 4,578,867 shares of the company’s stock valued at $174,882,000 after buying an additional 779,109 shares during the last quarter. 16.68% of the stock is currently owned by institutional investors.
American Healthcare REIT Company Profile
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
See Also
- Five stocks we like better than American Healthcare REIT
- 3 Fintech Stocks With Good 2021 Prospects
- Are These 3 Oversold Tech Giants Ready to Rebound?
- Roth IRA Calculator: Calculate Your Potential Returns
- If You Wait for the Dip, Micron Technology Could Leave You Behind
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks Quietly Powering the AI and Tech Revolution
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
